Brodalumab binds to the interleukin-17 receptor and so prevents interleukin 17 (IL-17) from activating the receptor. This mechanism is similar to that of another anti-psoriasis antibody, ixekizumab, which …

Who should not use SILIQ? Do not use SILIQ if you are allergic to brodalumab or any of the ingredients in SILIQ or if you have Crohn’s disease.

Feb 2, 2026 · Brodalumab is used to treat moderate to severe plaque psoriasis in adults. brodalumab is usually given after other treatments have failed. Brodalumab is available only under a special program.

Brodalumab is a human monoclonal IgG2κ antibody directed against human interleukin-17 receptor A (IL-17RA). It is expressed in a Chinese Hamster Ovary (CHO) cell line.

Feb 1, 2026 · Brodalumab injection is used to treat moderate to severe plaque psoriasis, which is a skin disease with red patches and white scales that do not go away. It is given to patients who did not …

Brodalumab (Siliq) is used for moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy and have failed to respond or have lost response to other systemic …

Jul 1, 2025 · Find clinical guidance on Brodalumab, including indications, dosing, safety, side effects and evidence-based insights for healthcare professionals.

Brodalumab injection is used to treat moderate to severe plaque psoriasis (skin disease in which red, scaly patches form on some areas of the body) in people whose psoriasis is too severe to be treated …

Aug 8, 2023 · Brodalumab is a monoclonal antibody approved by the United States Food and Drug Administration (FDA) to treat moderate to severe plaque psoriasis in adult patients who have failed …

Brodalumab Adult Medication This information from Lexicomp ® explains what you need to know about this medication, including what it’s used for, how to take it, its side effects, and when to call your …